Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

Clinical trial NCT06327100 · RECRUITING

Trial details

NCT number: NCT06327100
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-polycythemia Vera Myelofibrosis Post-Essential Thrombocytosis Myelofibrosis

Start date: 2024-08-01
Primary completion: 2029-05-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.